Quoin Pharmaceuticals (QNRX) Operating Leases (2019 - 2020)
Quoin Pharmaceuticals' (QNRX) quarterly Operating Leases came in at $122000.0 in Q4 2020, down 21.29% quarter-over-quarter from $155000.0 in Q2 2020.
Analysis
Quoin Pharmaceuticals (QNRX) Operating Leases (2019 - 2020) Analysis & Trends
Quoin Pharmaceuticals has disclosed Operating Leases across 2 years of filings, most recently posting $122000.0 for Q4 2020.
- In Q4 2020, Operating Leases changed N/A year-over-year to $122000.0; the TTM figure through Dec 2020 stood at $122000.0 (changed N/A YoY), while the FY2020 annual figure was $122000.0, changed N/A from the prior year.
- Operating Leases came in at $122000.0 for Q4 2020 at Quoin Pharmaceuticals, down from $155000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $243000.0 in Q2 2019 to a low of $122000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | Quoin Pharmaceuticals | 685,561.82 | 685,561.82 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 122,000.00 |
| Jun 30, 2020 | 155,000.00 |
| Jun 30, 2019 | 243,000.00 |